Eton Pharmaceuticals, Inc.:公司现预计2026年调整后EBITDA利润率至少达35%

美股速递
Aug 14

Eton Pharmaceuticals, Inc.今日宣布,其预期已大幅上调。公司最新展望显示,2026年调整后的EBITDA利润率将不低于35%。这一数字,无疑展现了其强劲的盈利前景和运营效率的提升。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10